Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

REGN - Regeneron Pharmaceuticals, Inc.


IEX Last Trade
1184.19
5.260   0.444%

Share volume: 405,349
Last Updated: Fri 30 Aug 2024 09:59:59 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology): 0.21%

PREVIOUS CLOSE
CHG
CHG%

$1,178.93
5.26
0.45%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 2022-09-30 2022-12-31 2023-03-31 2023-06-30 2023-09-30 2023-12-31 2024-03-31 2024-06-30
Fiscal Quarter Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024
Report Date 2022-11-03 2023-02-06 2023-05-04 2023-08-03 2023-11-02 2024-02-05 2024-05-02 2024-08-01
Total revenue 2.936 B 3.414 B 3.162 B 3.158 B 3.363 B 3.434 B 3.145 B 3.547 B
Cost of revenue 141.300 M 302.200 M 208.400 M 192.400 M 224.500 M 306.800 M 240.400 M 257.800 M
Gross profit 2.795 B 3.112 B 2.954 B 2.966 B 3.138 B 3.128 B 2.905 B 3.289 B
    11.35% -5.09% 0.41% 5.82% -0.34% -7.13% 13.24%  
Operating expenses 1.440 B 1.704 B 1.702 B 1.737 B 1.716 B 1.915 B 1.937 B 1.959 B
Selling general and admin 529.100 M 660.500 M 601.100 M 652.000 M 640.500 M 737.700 M 689.000 M 758.800 M
Research and development 911.300 M 1.043 B 1.101 B 1.085 B 1.075 B 1.177 B 1.248 B 1.200 B
Total expenses 1.758 B 2.244 B 2.160 B 2.142 B 2.152 B 2.432 B 2.371 B 2.439 B
    27.64% -3.76% -0.81% 0.47% 13.00% -2.50% 2.86%  
Operating income 1.178 B 1.170 B 1.002 B 1.016 B 1.211 B 1.002 B 773.800 M 1.108 B
Ebit 1.224 B 1.170 B 1.002 B 1.016 B 1.211 B 1.002 B 773.800 M 1.108 B
Pretax income 1.510 B 1.325 B 858.000 M 1.083 B 1.111 B 1.148 B 700.700 M 1.628 B
    -12.26% -35.23% 26.21% 2.58% 3.31% -38.94% 132.35%  
Income tax 194.100 M 127.600 M 40.200 M 114.500 M 103.000 M -12.000 M -21.300 M 195.800 M
Net income basic 1.316 B 1.197 B 817.800 M 968.400 M 1.008 B 1.160 B 722.000 M 1.432 B
    -9.01% -31.68% 18.42% 4.07% 15.06% -37.74% 98.38%  
Net income 1.316 B 1.197 B 817.800 M 968.400 M 1.008 B 1.160 B 722.000 M 1.432 B
    -9.01% -31.68% 18.42% 4.07% 15.06% -37.74% 98.38%